This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of eye and adnexa
C3_EYE_ADNEXA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
347 |
4. Check minimum number of eventsNone |
347 |
5. Include endpointsNone |
347 |
6. Filter based on genotype QC (FinnGen only) |
313 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of eye and adnexa
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of eye and adnexa, including Hilmo
- Malignant neoplasm of eye, brain and central nervous system
- Malignant neoplasm of eye, brain and central nervous system, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 313 | 143 | 170 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.08 |
| Median age at first event (years) | 61.93 | 59.09 | 64.31 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 317
- Matched controls
- 3170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
XCD10
NOMESCO Finland
Electrophysiological examination of eye
78.8
258.3
146
34
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
199.8
170
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
174.6
151
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
174.6
151
*
WX140
NOMESCO Finland
Parabulbar anesthesy
27.9
169.7
133
80
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
146.6
129
*
XCK10
NOMESCO Finland
Photography of fundus of eye
15.4
131.8
154
183
H02AB02
ATC
dexamethasone; systemic
69.8
112.1
62
11
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
13.0
95.5
111
126
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
93.5
85
*
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
87.7
80
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
170.4
86.0
87
7
130
Kela drug reimbursment
Malignant tumour
+∞
81.9
75
*
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
75.0
69
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
64.9
60
*
JN4BD
NOMESCO Finland
Extensive body CT
13.0
62.5
66
63
Z3229
NOMESCO Finland
Other healthcare associate professional
8.3
61.4
99
164
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
7.7
60.0
106
194
XCW99
NOMESCO Finland
Other investigative procedure of eye
7.6
59.6
107
199
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
10.1
58.9
76
96
WX002
NOMESCO Finland
Sedation and analgesia
6.3
56.7
141
359
A04AA01
ATC
ondansetron; systemic, rectal
16.0
53.1
48
35
A03FA01
ATC
metoclopramide; systemic, rectal
6.7
51.9
106
222
Z51.5
ICD-10 Finland
Palliative care
10.4
47.7
58
67
ZXD10
NOMESCO Finland
Scheduled procedure
5.3
47.1
203
797
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
112.7
45.2
48
5
WF002
NOMESCO Finland
Radical radiotherapy
165.2
41.9
43
*
ZXA05
NOMESCO Finland
Left side
4.8
41.8
154
524
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
41.6
39
*
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
41.6
39
*
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
123.9
40.9
43
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
15.4
40.6
37
27
Z2221
NOMESCO Finland
Medical doctor
4.7
39.9
146
491
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
39.4
37
*
A04AA02
ATC
granisetron; systemic, transdermal
426.2
38.9
38
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
413.4
37.9
37
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
37.2
35
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
83.2
33.6
37
5
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
7.1
33.6
56
93
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
45.5
33.0
40
10
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
30.7
29
*
ZXE00
NOMESCO Finland
One hour or less
3.8
30.6
179
806
XX3DW
NOMESCO Finland
Time consuming IT work
8.3
30.5
43
59
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.1
29.8
113
378
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
29.6
28
*
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
29.6
28
*
9510/3-C69.2
ICD-O-3
Retinoblastoma, NOS, of retina
+∞
29.6
28
*
CAA30
NOMESCO Finland
Biopsy of orbit
+∞
29.6
28
*
S01ED51
ATC
timolol, combinations; ophthalmic
5.3
29.2
68
155
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
28.6
27
*
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
28.6
28.2
38
15
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
159.0
28.1
29
*
ZXA00
NOMESCO Finland
Right side
3.6
27.5
139
561
WZC00
NOMESCO Finland
Treatment plan or consultation
3.7
27.4
134
529
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
26.4
25
*
CF2S4
NOMESCO Finland
Photography of conjunctiva
+∞
26.4
25
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.4
25.5
158
717
N02AA05
ATC
oxycodone; systemic
3.9
25.4
95
311
XW000
NOMESCO Finland
Bone marrow biopsy
23.7
25.4
36
17
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
25.3
24
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
24.3
23
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
24.3
23
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
247.1
22.9
23
*
JN4AD
NOMESCO Finland
Body CT examination
5.5
22.3
47
97
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
22.1
21
*
L03AA13
ATC
pegfilgrastim; parenteral
123.6
21.9
23
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.9
21.7
28
34
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
36.7
21.5
27
8
S01ED01
ATC
timolol; ophthalmic
7.1
20.9
33
51
WF049
NOMESCO Finland
Radiotherapy of metastasis
224.1
20.8
21
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
20.0
19
*
C69.21
ICD-10 Finland
Retina
+∞
20.0
19
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
112.1
19.8
21
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.6
19.5
33
55
L01AX03
ATC
temozolomide; systemic
+∞
18.9
18
*
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
201.4
18.7
19
*
JN4CD
NOMESCO Finland
Very extensive body CT
17.6
18.7
29
18
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.0
18.2
29
45
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
21.7
18.1
26
13
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
21.7
18.1
26
13
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
15.8
18.0
29
20
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
17.9
17
*
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
17.9
17
*
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
17.9
17
*
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
17.9
17
*
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
100.8
17.8
19
*
H26.2
ICD-10 Finland
Complicated cataract
20.8
17.2
25
13
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
16.8
16
*
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
16.8
16
*
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
179.0
16.7
17
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
179.0
16.7
17
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.7
16.6
179
1031
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.4
15.9
43
109
JN6AD
NOMESCO Finland
CT of torso and neck
28.0
15.8
21
8
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.8
15
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.8
15
*
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
15.8
15
*
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
89.6
15.7
17
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
167.9
15.6
16
*
CDC00
NOMESCO Finland
Enucleation of eye
167.9
15.6
16
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
15.4
102
457
CD2S4
NOMESCO Finland
Photography of eye
47.5
15.2
18
*
Z3231
NOMESCO Finland
Registered nurse
2.7
14.8
112
535
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
14.8
183
1106
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
14.7
14
*
180
Kela drug reimbursment
Interferon alfa
+∞
14.7
14
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
14.7
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
C69.20
ICD-10 Finland
Retina
+∞
14.7
14
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
14.7
14
*
116
Kela drug reimbursment
Prostate cancer
+∞
14.7
14
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
156.9
14.6
15
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
14.3
58
195
CBA10
NOMESCO Finland
Biopsy of eyelid
31.7
14.0
18
6
Z97.0
ICD-10 Finland
Presence of artificial eye
55.9
13.9
16
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.5
13.8
151
855
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
13.6
13
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
13.6
13
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
13.6
13
*
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
+∞
13.6
13
*
3779
FHL
Other operations in this group include disc removal
146.0
13.6
14
*
WX142
NOMESCO Finland
Sub-tenon anesthesy
25.5
12.6
17
7
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
12.6
12
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
12.6
12
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
12.6
12
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
12.6
12
*
CA1ME
NOMESCO Finland
Ultrasound oculometry
24.0
11.7
16
7
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.5
11
*
CAW99
NOMESCO Finland
Other operation on orbit
+∞
11.5
11
*
JJ1AQ
NOMESCO Finland
Liver SPECT with low dose CT
+∞
11.5
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
124.3
11.5
12
*
L03AA02
ATC
filgrastim; parenteral
124.3
11.5
12
*
HA1AA
NOMESCO Finland
X-ray mammography
5.8
11.3
21
38
WZC30
NOMESCO Finland
Teaching
2.9
10.9
58
228
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.5
10.8
27
64
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
5.7
10.5
20
37
ZX120
NOMESCO Finland
Intravenous
3.7
10.5
35
103
C69.45
ICD-10 Finland
Melanoma of iris
+∞
10.5
10
*
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
10.5
10
*
CH2S4
NOMESCO Finland
Photography of iris
+∞
10.5
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.5
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.5
10
*
C69.0
ICD-10 Finland
Malignant neoplasm: Conjunctiva
+∞
10.5
10
*
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
+∞
10.5
10
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
33.8
10.4
13
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.9
10.2
23
50
ZXE20
NOMESCO Finland
More than three and less than five hours
2.9
10.1
54
212
L02AE02
ATC
leuprorelin; implant, parenteral
41.5
10.0
12
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
27.0
9.9
13
5
Z31.5
ICD-10 Finland
Genetic counselling
4.9
9.7
22
48
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
3.5
9.5
35
110
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
18.2
9.5
14
8
A06AH03
ATC
naloxegol; oral
31.1
9.5
12
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
103.0
9.5
10
*
F74
ICPC
Neoplasm of eye/adnexa
+∞
9.4
9
*
C69.63
ICD-10 Finland
Malignant tumor of orbital carcinoma
+∞
9.4
9
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
9.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
8720/3-C69.0
ICD-O-3
Malignant melanoma, NOS, of conjunctiva
+∞
9.4
9
*
C69.2
ICD-10 Finland
Malignant neoplasm: Retina
+∞
9.4
9
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
9.4
9
*
1905A
ICD-9 Finland
Malignant neoplasm of eye, Retina[RETINOBLASTOMA RETINAE]
+∞
9.4
9
*
19003
ICD-8 Finland
Malignant neoplasm of eye, Retinae
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
C69.29
ICD-10 Finland
Retina
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
H43.1
ICD-10 Finland
Vitreous haemorrhage
7.7
9.4
21
29
ZXA10
NOMESCO Finland
Bilateral
2.3
9.0
83
423
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.0
8.8
19
25
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
51.4
8.7
10
*
CA1AD
NOMESCO Finland
Orbita CT
92.4
8.5
9
*
Y77
ICPC
Malignant neoplasm prostate
92.4
8.5
9
*
L02BB03
ATC
bicalutamide; oral
+∞
8.4
8
*
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
8.4
8
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.4
8
*
CFD10
NOMESCO Finland
Repair of conjunctiva
+∞
8.4
8
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
8.4
8
*
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
+∞
8.4
8
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
8.4
8
*
C69.91
ICD-10 Finland
Malignant tumor in unspecified localization in the eye retinoblastoma
+∞
8.4
8
*
S01EC01
ATC
acetazolamide; systemic
5.0
8.2
18
38
H05.2
ICD-10 Finland
Exophthalmic conditions
34.3
8.1
10
*
S01EA05
ATC
brimonidine; ophthalmic
6.7
7.8
19
30
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.7
7.7
18
40
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.3
7.7
71
359
WX400
NOMESCO Finland
Inhalation anesthesy
4.6
7.5
18
41
XCH00
NOMESCO Finland
Eye pressure measurement
3.3
7.5
29
94
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
81.9
7.4
8
*
3102
FHL
Enucleation
81.9
7.4
8
*
CB9S4
NOMESCO Finland
Photography of eyelids and eyebrows
81.9
7.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
81.9
7.4
8
*
ZX112
NOMESCO Finland
Subcutaneous
13.8
7.4
12
9
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.7
7.4
15
18
S01EA03
ATC
apraclonidine; ophthalmic
9.7
7.4
14
15
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
7.4
61
295
C69.90
ICD-10 Finland
Malignant tumor in unspecified localization in eye without histology
+∞
7.3
7
*
9591/3-C69.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS
+∞
7.3
7
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
7.3
7
*
A79
ICPC
Malignancy NOS
+∞
7.3
7
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
7.3
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.3
7
*
H05.0
ICD-10 Finland
Acute inflammation of orbit
+∞
7.3
7
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
QX2AN
NOMESCO Finland
Other soft tissue tumour isotope imaging
+∞
7.3
7
*
C69.4
ICD-10 Finland
Malignant neoplasm: Ciliary body
+∞
7.3
7
*
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
16.2
7.3
11
7
WW500
NOMESCO Finland
Blood transfusion
8.2
7.2
15
19
S01EE01
ATC
latanoprost; ophthalmic
2.9
7.1
34
125
H02.4
ICD-10 Finland
Ptosis of eyelid
4.4
7.1
18
43
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.9
6.9
18
32
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
41.0
6.8
8
*
XCD20
NOMESCO Finland
Photoangiography of eye
7.4
6.8
15
21
H16.0
ICD-10 Finland
Corneal ulcer
3.4
6.7
24
74
XCK00
NOMESCO Finland
Perimetry
3.0
6.6
29
102
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
14.7
6.4
10
7
Z2446
NOMESCO Finland
Social worker
2.9
6.4
30
109
C69.69
ICD-10 Finland
Malignant tumor in orbital other or unspecified histology
+∞
6.3
6
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
6.3
6
*
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
+∞
6.3
6
*
CKE40
NOMESCO Finland
Transpupillary photocoagulation of lesion of retina
+∞
6.3
6
*
ZZL00
NOMESCO Finland
Free graft of amniotic membrane
+∞
6.3
6
*
CCA10
NOMESCO Finland
Biopsy of lacrimal gland
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.7
6.3
20
57
HAB40
NOMESCO Finland
Wedge excision of mammary gland
27.3
6.3
8
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.6
6.2
17
32
CBB30
NOMESCO Finland
Excision of lesion of eyelid
6.0
6.2
16
28
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
12.9
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
184
833
3.88
31.41
6.1
2.9
31.28
35.84
u/l
0.82
177
785
55
141
4.51
20.19
2.7
1.4
3.20
2.62
ug/l
0.54
41
111
35
62
6.22
19.44
1.8
1.7
18.60
95.63
u/ml
0.45
30
47
217
1400
2.74
15.65
17.4
6.1
3.78
4.25
e9/l
3.60
196
1218
262
1929
3.06
13.52
16.1
5.7
90.93
78.32
u/l
2.62
253
1795
181
1140
2.37
12.66
6.8
3.9
34.90
35.77
g/l
1.18
174
1057
21
26
8.57
10.00
1.2
1.2
—
—
—
0
0
9
0
+∞
9.42
1.2
0.0
—
—
—
0
0
191
1345
2.06
8.80
9.3
6.5
1.21
1.21
mmol/l
0.37
164
1155
174
1193
2.02
8.54
8.0
6.2
1.21
1.21
mmol/l
0.11
167
1082
137
865
2.03
8.47
7.1
2.1
2.36
2.36
mmol/l
0.02
128
758
19
29
6.90
8.01
1.8
1.7
3.70
130.27
u/ml
0.48
19
29
14
15
9.70
7.36
1.9
2.0
0.79
0.74
e9/l
0.08
14
15
7
0
+∞
7.32
1.3
0.0
21.89
—
%
—
7
0
7
0
+∞
7.32
1.0
0.0
8.66
—
%
—
7
0
7
0
+∞
7.32
1.3
0.0
36.80
—
%
—
7
0
59
286
2.31
7.06
4.2
2.5
13.38
6.06
umol/l
1.01
48
250
108
694
1.84
5.89
2.7
2.5
320.96
358.02
umol/l
2.47
96
599
203
1598
1.75
5.31
5.9
4.9
6.75
6.75
mmol/l
0.00
197
1516
5
0
+∞
5.22
2.4
0.0
0.06
—
ug/l
—
5
0
170
1308
1.65
4.55
13.3
15.7
1.28
1.30
inr
0.20
149
1092
88
573
1.74
4.42
3.3
2.2
—
—
—
0
0
149
1119
1.63
4.33
3.4
2.5
—
—
estimate
—
0
0
84
543
1.74
4.32
5.1
2.1
2.46
2.45
mmol/l
0.55
78
476
10
19
5.40
3.86
1.2
1.3
—
—
—
0
0
62
390
1.73
3.46
2.3
2.3
20.55
23.05
%
0.83
56
361
115
854
1.54
3.29
4.1
2.3
59.75
62.46
u/l
0.17
110
792
11
29
3.89
3.21
2.8
1.3
34.00
34.00
pg
0.00
11
29
6
9
6.77
2.88
1.0
1.4
—
—
—
0
0
39
229
1.80
2.75
2.1
2.0
27.00
37.18
u/l
1.54
32
183
15
60
2.57
2.74
3.6
2.0
44.67
31.98
umol/l
1.47
15
53
7
14
5.09
2.74
2.0
2.0
13.00
16.14
%
—
7
14
11
38
2.96
2.44
1.3
1.6
—
—
—
0
0
223
2460
0.68
2.37
6.5
7.1
39.15
39.99
mmol/mol
0.82
212
2304
5
9
5.62
2.22
1.0
1.1
—
—
—
0
0
105
1306
0.71
2.20
2.4
2.2
93.89
95.96
pmol/l
0.17
56
656
6
14
4.35
2.16
2.2
4.1
—
—
—
0
0
6
14
4.35
2.16
2.3
2.2
—
—
—
0
0
49
328
1.58
2.16
5.3
8.0
0.55
1.25
mmol/l
0.54
43
272
18
88
2.11
2.16
2.1
3.0
—
—
—
0
0
228
2493
0.70
2.14
4.8
5.4
1.39
1.45
mmol/l
1.22
217
2289
230
2510
0.70
2.12
5.0
5.5
4.50
4.49
mmol/l
0.06
218
2322
8
25
3.26
2.11
1.0
1.3
—
—
—
0
0
5
10
5.06
2.08
1.2
2.5
3.04
4.21
nmol/l
—
5
10
98
763
1.41
2.06
3.2
3.1
0.10
0.35
e6/l
3.63
74
561
15
70
2.20
2.01
2.5
1.2
4.29
1.49
ratio
—
9
43
91
1142
0.72
1.95
2.0
2.0
1.40
1.32
mmol/l
0.44
83
951
238
2556
0.72
1.65
5.6
6.3
2.61
2.59
mmol/l
0.09
225
2354
58
427
1.44
1.65
2.9
3.2
0.43
2.35
e6/l
3.61
30
205
11
50
2.24
1.59
1.2
1.3
—
—
—
0
0
11
50
2.24
1.59
1.2
1.3
—
—
—
0
0
269
2519
1.45
1.57
24.6
14.8
26.44
23.88
mg/l
0.64
244
2022
61
459
1.41
1.54
2.5
2.3
11.91
12.92
umol/l
0.47
56
428
221
2392
0.75
1.53
4.1
4.6
1.34
1.27
mmol/l
0.78
210
2181
46
626
0.69
1.53
1.6
1.8
576.33
7737379.48
pmol/l
0.50
39
517
83
1024
0.74
1.52
4.7
4.2
14.55
7.43
mg/mmol
0.55
55
642
40
278
1.50
1.52
2.9
3.1
—
—
—
0
0
233
2499
0.74
1.47
5.2
5.5
5.92
6.04
mmol/l
0.85
211
2273
12
59
2.07
1.45
3.6
1.7
—
—
—
0
0
6
22
2.76
1.44
1.0
1.4
—
—
—
0
0
61
470
1.37
1.35
2.8
2.9
0.87
1.05
e6/l
0.18
33
249
6
24
2.53
1.31
1.0
1.0
—
—
—
0
0
6
24
2.53
1.31
2.2
1.7
2243.17
929.17
mg
—
6
24
61
474
1.36
1.28
1.7
1.8
—
—
—
0
0
14
77
1.86
1.27
11.6
4.8
1.07
1.66
mg/l
4.33
14
68
12
63
1.94
1.24
1.2
1.6
—
—
—
0
0
46
343
1.40
1.24
6.6
5.8
1.10
1.06
mmol/l
0.29
41
314
23
149
1.59
1.21
7.7
11.6
16.10
16.19
%
0.05
23
144
73
891
0.77
1.20
2.1
1.7
19.36
20.27
nmol/l
0.23
68
753
183
1651
1.26
1.20
4.5
3.3
77.51
48.36
u/l
1.84
172
1547
0
34
0.00
1.16
0.0
1.2
—
—
—
0
0
11
58
1.93
1.13
1.2
1.3
—
—
—
0
0
11
60
1.86
1.04
1.5
2.2
—
—
—
0
0
0
30
0.00
0.98
0.0
1.2
—
—
—
0
0
0
30
0.00
0.98
0.0
1.2
—
—
—
0
0
225
2386
0.80
0.97
6.2
5.2
1.80
1.96
mu/l
1.43
210
2169
28
201
1.43
0.95
2.7
2.2
55.18
60.93
ml/min/173m2
0.50
11
83
9
52
1.75
0.93
1.1
1.3
—
—
—
0
0
15
230
0.63
0.93
1.5
1.6
—
—
—
0
0
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
7
126
0.55
0.90
1.1
1.3
—
—
—
0
0
21
144
1.49
0.90
3.6
6.8
1.52
1.63
%
0.15
21
138
68
565
1.26
0.89
2.1
2.0
1.35
1.30
mg/l
0.05
60
450
37
476
0.75
0.89
1.6
1.3
33.29
36.14
iu/ml
0.07
14
142
11
64
1.74
0.87
1.3
1.4
—
—
—
0
0
276
2654
1.31
0.85
20.4
10.5
31.46
25.40
u/l
1.43
267
2565
6
31
1.95
0.85
1.0
1.0
—
—
—
0
0
6
31
1.95
0.85
1.0
1.5
—
—
—
0
0
6
115
0.51
0.84
1.0
1.1
—
—
—
0
0
11
65
1.72
0.83
1.8
1.4
—
—
—
0
0
6
32
1.89
0.82
2.5
4.7
—
—
—
0
0
13
82
1.61
0.79
1.2
1.3
—
—
—
0
0
5
99
0.50
0.79
2.2
1.9
3.11
2.55
mg/l
—
5
69
0
26
0.00
0.79
0.0
1.0
—
47.90
—
0
18
0
26
0.00
0.79
0.0
1.0
—
524.79
—
0
19
15
99
1.54
0.77
1.5
1.7
—
—
—
0
0
14
91
1.56
0.76
1.4
1.5
—
—
—
0
0
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
219
2066
1.19
0.74
30.2
18.4
14.05
13.63
%
3.86
219
2041
9
55
1.65
0.74
1.1
1.1
—
5.29
—
0
9
7
38
1.86
0.74
1.3
1.6
—
—
—
0
0
43
527
0.79
0.73
1.8
1.8
1107.37
1227.80
nmol/l
0.45
33
406
35
440
0.77
0.73
1.5
1.3
39.58
12.59
u/ml
—
10
164
5
25
2.02
0.73
2.0
1.9
—
—
—
0
0
7
39
1.81
0.73
1.1
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
76
1.60
0.72
1.6
8.3
0.47
0.40
iu/ml
—
7
40
20
143
1.43
0.72
1.6
1.5
—
—
—
0
0
24
180
1.36
0.67
1.8
1.5
—
—
—
0
0
73
835
0.84
0.65
4.0
4.0
24.13
24.44
%
0.06
43
410
49
582
0.81
0.64
1.3
1.3
0.43
1.37
u/ml
—
9
147
5
29
1.74
0.64
1.0
1.2
—
1.07
—
0
6
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
208
1971
1.16
0.60
5.1
4.4
12.12
11.68
mm/h
0.17
195
1823
0
22
0.00
0.59
0.0
1.1
—
181.08
—
0
22
51
598
0.82
0.59
3.1
2.9
0.91
0.78
ug/l
0.39
37
398
16
115
1.41
0.58
1.8
1.2
7.61
7.44
g/l
0.16
16
100
16
115
1.41
0.58
1.8
1.2
4.35
4.34
g/l
0.02
16
100
14
98
1.45
0.57
1.9
1.1
9.90
10.47
g/l
0.18
14
83
20
151
1.35
0.55
2.0
3.0
23.94
25.11
mmol/l
0.67
20
145
41
344
1.22
0.52
1.6
1.8
—
—
—
0
0
6
40
1.51
0.52
1.2
1.1
—
—
—
0
0
34
283
1.23
0.47
1.2
1.5
—
—
—
0
0
7
50
1.41
0.45
1.9
2.2
—
—
—
0
0
10
69
1.46
0.45
1.0
1.1
—
—
—
0
0
5
31
1.62
0.43
1.2
1.6
—
—
—
0
0
8
58
1.39
0.42
1.0
1.3
—
132.00
—
0
5
151
1424
1.12
0.41
3.7
3.9
38.97
0.00
estimate
0.49
34
286
0
15
0.00
0.41
0.0
1.5
—
0.94
—
0
9
0
15
0.00
0.41
0.0
1.5
—
1.26
—
0
9
0
15
0.00
0.41
0.0
1.5
—
0.99
—
0
9
8
60
1.34
0.40
1.1
1.3
—
—
—
0
0
42
364
1.18
0.40
1.7
1.8
—
—
—
0
0
276
2699
1.17
0.40
31.3
19.8
80.42
79.51
umol/l
0.16
271
2667
15
115
1.32
0.39
1.9
1.2
3.65
3.76
g/l
0.17
15
100
100
1079
0.89
0.39
3.9
3.8
0.00
0.01
estimate
0.50
28
219
95
1028
0.89
0.39
5.3
4.4
2.77
2.03
ug/l
1.32
86
917
269
2627
1.16
0.39
27.0
18.8
139.52
139.79
mmol/l
0.91
263
2576
132
1400
0.90
0.38
2.5
2.7
—
—
—
0
0
29
339
0.84
0.35
4.3
5.4
31.00
32.38
%
0.29
24
219
66
599
1.13
0.35
5.3
4.3
556.93
339.30
ng/l
0.19
59
488
269
2632
1.15
0.34
27.2
18.9
4.00
4.00
mmol/l
0.02
262
2573
70
761
0.90
0.31
3.2
3.3
0.00
0.00
estimate
-0.00
25
217
247
2410
1.11
0.31
24.2
14.3
80.15
76.18
ml/min/173m2
2.70
229
2233
33
288
1.16
0.30
1.8
2.5
5.01
7.24
ug/l
0.57
26
252
7
56
1.26
0.29
1.0
1.1
—
4.98
—
0
5
17
140
1.23
0.28
1.4
1.2
92.56
106.26
u/ml
—
5
56
15
122
1.24
0.27
5.8
6.8
25.29
24.86
mmol/l
0.40
15
114
8
66
1.22
0.27
1.5
1.3
—
3.16
—
0
5
150
1438
1.08
0.26
3.8
3.9
0.00
0.01
estimate
0.50
32
268
5
71
0.70
0.26
1.6
1.5
—
—
—
0
0
5
75
0.66
0.26
1.0
1.9
190.00
233.83
pmol/l
—
5
69
23
198
1.17
0.25
3.7
7.2
25.01
24.98
mmol/l
0.01
23
191
114
1195
0.93
0.23
2.8
2.5
78.84
77.96
nmol/l
0.11
106
1065
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
5
41
1.22
0.22
1.0
1.2
10.63
16.15
u/l
—
5
33
21
182
1.16
0.22
1.5
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
9.83
—
0
12
10
80
1.26
0.20
1.1
1.2
0.00
0.00
g/l
—
10
70
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
146
1413
1.06
0.18
3.7
3.9
0.00
0.00
estimate
-0.00
31
278
7
59
1.19
0.18
1.0
1.6
—
—
—
0
0
83
790
1.07
0.17
3.7
3.9
0.00
0.01
estimate
0.50
27
263
7
61
1.15
0.17
1.3
1.4
—
—
—
0
0
7
61
1.15
0.17
1.1
1.1
—
—
—
0
0
20
177
1.14
0.16
4.7
5.8
2.24
2.16
mmol/l
0.04
15
128
34
312
1.10
0.16
8.0
3.5
1.88
1.76
mmol/l
0.06
28
266
10
83
1.21
0.15
1.1
1.1
0.00
0.00
g/l
—
10
76
19
169
1.13
0.15
12.2
3.9
24.91
24.27
mmol/l
0.37
19
169
34
315
1.09
0.14
7.9
3.5
5.43
5.73
kpa
1.08
34
306
17
154
1.11
0.10
1.6
1.9
—
—
—
0
0
276
2738
1.06
0.10
36.2
22.5
239.69
243.51
e9/l
0.40
270
2691
15
135
1.12
0.10
1.6
1.9
—
—
—
0
0
19
174
1.10
0.09
3.0
3.8
46.35
48.00
%
0.10
19
169
29
272
1.07
0.09
8.4
3.2
4.45
4.46
kpa
0.01
29
263
276
2740
1.06
0.09
36.2
22.5
4.43
4.49
e12/l
1.15
269
2681
90
924
0.96
0.08
2.6
2.2
155.35
198.79
u/l
0.66
84
870
8
74
1.08
0.07
2.1
1.3
543.38
473.04
mg/l
—
8
69
31
326
0.95
0.07
9.0
6.8
—
—
—
0
0
37
356
1.04
0.05
1.3
1.6
—
—
—
0
0
16
171
0.93
0.05
3.8
2.4
0.74
0.63
%
0.51
16
171
66
648
1.02
0.03
4.0
4.1
1.02
1.02
kg/l
0.42
49
423
97
981
0.98
0.02
3.7
3.5
1643.10
1442.40
ng/l
0.22
83
837
12
113
1.06
0.02
1.4
2.1
83.67
300.19
ug/l
2.67
12
105
16
153
1.05
0.01
4.4
3.5
1.02
1.02
ratio
0.20
16
143
20
206
0.97
0.00
3.5
2.9
121.10
130.69
g/l
1.08
20
200
199
1984
1.01
0.00
5.3
4.1
14.82
14.90
pmol/l
0.19
184
1786
115
1148
1.00
0.00
4.4
4.0
40.88
40.22
ng/l
0.01
92
871
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
5
53
0.94
0.00
4.0
2.5
20.76
9.04
pmol/l
—
5
53
0
5
0.00
-0.00
0.0
1.0
—
22.50
—
0
5
0
9
0.00
-0.00
0.0
1.8
—
57.16
—
0
9
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
71
0.99
-0.00
1.4
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
9.78
—
0
8
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
-0.00
2.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
7.78
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
0.21
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
—
—
0
0
6
59
1.02
-0.00
1.3
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_EYE_ADNEXA – Malignant neoplasm of eye and adnexa
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).